DETAILED INVESTIGATION OF IMMUNE FUNCTION IN PATIENTS (PTS) RECEIVING THE IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) - NO EVIDENCE OF ABNORMALITY AFTER 3 YEARS OF THERAPY

被引：0
|
作者：
BERKOVITCH, M [1 ]
MEYDAN, N [1 ]
DONSKY, J [1 ]
COLLINS, AF [1 ]
SHER, GD [1 ]
MATSUI, D [1 ]
KOREN, G [1 ]
HACKMAN, R [1 ]
ROIFMAN, C [1 ]
OLIVIERI, NF [1 ]
机构：
[1] HOSP SICK CHILDREN,TORONTO M5G 1X8,ONTARIO,CANADA
来源：
PEDIATRIC RESEARCH | 1994年 / 35卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：A158 / A158
页数：1
相关论文
共 50 条
  • [1] DETAILED INVESTIGATION OF IMMUNE FUNCTION IN PATIENTS (PTS) RECEIVING THE IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) - NO EVIDENCE OF ABNORMALITY AFTER 3 YEARS OF THERAPY
    BERKOVITCH, M
    MEYDAN, N
    DONSKY, J
    COLLINS, AF
    SHER, GD
    MATSUI, D
    KOREN, G
    HACKMAN, R
    ROIFMAN, C
    OLIVIERI, NF
    BLOOD, 1993, 82 (10) : A360 - A360
  • [2] USE OF THE NEW ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) IN THALASSEMIA PATIENTS
    MATSUI, D
    OLIVIERI, N
    KOREN, G
    TEMPLETON, D
    LIU, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (02) : 144 - 144
  • [3] LONG-TERM TRIAL WITH THE ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1)
    KONTOGHIORGHES, GJ
    BARTLETT, AN
    HOFFBRAND, AV
    GODDARD, JG
    SHEPPARD, L
    BARR, J
    NORTEY, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 (02) : 295 - 300
  • [4] RETINAL TOXICITY OF THE IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE, (L1), IN AN ALBINO-RAT MODEL
    PURPLE, RL
    SCHAUER, BA
    GEHLBACH, PL
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S163 - S163
  • [5] ZINC CONCENTRATION IN PATIENTS WITH IRON OVERLOAD RECEIVING ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE OR DESFERRIOXAMINE
    ALREFAIE, FN
    WONKE, B
    WICKENS, DG
    AYDINOK, Y
    FIELDING, A
    HOFFBRAND, AV
    JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (07) : 657 - 660
  • [6] STUDIES OF THE ORAL CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE IN THALASSEMIA PATIENTS
    OLIVIERI, NF
    KOREN, G
    STLOUIS, P
    FREEDMAN, MH
    MCCLELLAND, RA
    TEMPLETON, DM
    SEMINARS IN HEMATOLOGY, 1990, 27 (02) : 101 - 104
  • [7] ORAL IRON CHELATION WITH 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) IN IRON-LOADED THALASSEMIA PATIENTS
    OLIVIERI, NF
    MATSUI, D
    LIU, PP
    BLENDIS, L
    CAMERON, R
    MCCLELLAND, RA
    TEMPLETON, DM
    KOREN, G
    BONE MARROW TRANSPLANTATION, 1993, 12 : 9 - 11
  • [8] METHODOLOGICAL ISSUES IN STUDYING THE EFFECT OF THE NEW ORAL CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE(L1) ON ABSORPTION OF IRON
    BENTUR, Y
    KLEIN, J
    LEVY, M
    OLIVIERI, N
    MCGUIGAN, M
    KOREN, G
    VETERINARY AND HUMAN TOXICOLOGY, 1990, 32 (02) : 159 - 162
  • [9] PHARMACOKINETIC STUDIES IN HUMANS WITH THE ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE
    KONTOGHIORGHES, GJ
    GODDARD, JG
    BARTLETT, AN
    SHEPPARD, L
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (03) : 255 - 261
  • [10] EFFECTIVE IRON CHELATION USING THE ORAL IRON CHELATOR, 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1), IN HOMOZYGOUS BETA-THALASSEMIA MAJOR (HBT) PATIENTS (PTS)
    MATSUI, D
    OLIVIERI, N
    BERKOVITCH, M
    TEMPLETON, D
    WANLESS, I
    BLENDIS, L
    LIU, P
    KOREN, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (02) : 145 - 145
12345